ArticleFrontiers in immunology2022

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon.

Hong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.